RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 120 filers reported holding RA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 4.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,852,000 | +3.9% | 59,400 | +1.5% | 0.00% | 0.0% |
| Q4 2019 | $2,745,000 | +125.4% | 58,500 | +13.6% | 0.00% | +200.0% |
| Q3 2019 | $1,218,000 | -17.8% | 51,500 | +4.5% | 0.00% | -50.0% |
| Q2 2019 | $1,482,000 | +39.0% | 49,300 | +3.6% | 0.00% | +100.0% |
| Q1 2019 | $1,066,000 | +23.1% | 47,600 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $866,000 | +389.3% | 47,600 | +42.5% | 0.00% | – |
| Q1 2018 | $177,000 | +58.0% | 33,400 | +153.0% | 0.00% | – |
| Q4 2017 | $112,000 | -42.0% | 13,200 | 0.0% | 0.00% | – |
| Q3 2017 | $193,000 | -21.9% | 13,200 | 0.0% | 0.00% | – |
| Q2 2017 | $247,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
| RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
| HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
| SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
| Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
| Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
| Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |